Publication Cover
Materials Technology
Advanced Performance Materials
Volume 31, 2016 - Issue 6
272
Views
19
CrossRef citations to date
0
Altmetric
Research Paper

An investigation on the effect of β-CD modified Fe3O4 magnetic nanoparticles on aggregation of amyloid b peptide (25-35)

, , , &
Pages 315-321 | Received 22 Dec 2014, Accepted 27 Feb 2015, Published online: 06 Feb 2016
 

Abstract

In this study, β-cyclodextrin (β-CD)-functionalised Fe3O4 composite nanoparticles with core–shell structures were fabricated via carbodiimide activation, which were employed to interact with amyloid b (25–35) peptides (Aβ25–35). The functionalised magnetic core–shell nanoparticles (MNPs) were characterised by Transmission Electron Microscopy (TEM), Fourier Transform Infrared (FTIR) spectroscopy, Thermogravimetric analysis (TGA) and X-ray Diffraction, which verified that β-CD was successfully grafted on the surface of Fe3O4 MNPs. The effect of β-CD grafted on the Fe3O4 MNPs on the aggregation of amyloid-β-(25–35) peptides were investigated by atomic force microscopy (AFM) and Thioflavin T fluorescence measurements. The result showed that, without functionalized MNPs, the amyloid (25–35) peptides aggregated gradually from monomers and oligomers to long fibrils with the incubation time. In comparison, modified MNPs dramatically inhibited fibrilization and further aggregation. This study may contribute to the development of new diagnostic and therapeutic strategies against amyloid-related diseases.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.